BULLET BIOTECHNOLOGY, INC.

Profile

Company Names

BULLET BIOTECHNOLOGY, INC.

Addresses

2686 MIDDLEFIELD ROAD, SUITE D, REDWOOD CITY, CA 94063

3815 ALAMEDA DE LAS PULGAS, MENLO PARK, CA 94025

Phone Numbers

(650) 278-8958
650-269-7102

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$2,744,332.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-06-21 
$343,995.00 
$1,441,666.00 
$1,097,671.00 
Debt 
3
2015-03-09 
$699,834.00 
$2,500,000.00 
$1,800,166.00 
Equity, Debt 
2
2013-06-11 
$1,135,198.00 
$1,500,000.00 
$364,802.00 
Equity 
1
2012-02-03 
$565,305.00 
$1,480,916.00 
$915,611.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DIEGO 
 
FONSTAD 
EXECUTIVE OFFICER, DIRECTOR
BULLET BIOTECHNOLOGY, INC.
WILLIAM 
P 
QUINN 
EXECUTIVE OFFICER, DIRECTOR
BULLET BIOTECHNOLOGY, INC.
WILLIAM 
P. 
QUINN 
EXECUTIVE OFFICER, DIRECTOR
BULLET BIOTECHNOLOGY, INC.
MARK 
 
ROBBINS 
EXECUTIVE OFFICER
BULLET BIOTECHNOLOGY, INC.
MARK 
S. 
ROBBINS 
EXECUTIVE OFFICER
BULLET BIOTECHNOLOGY, INC.
SAMUEL 
 
SAKS 
DIRECTOR
AUSPEX PHARMACEUTICALS, INC.   |  TONIX PHARMACEUTICALS HOLDING CORP.   |  BULLET BIOTECHNOLOGY, INC.   |  HINGE BIO, INC.   |  QUANTA THERAPEUTICS, INC.
GLEN 
 
SATO 
EXECUTIVE OFFICER
ACUCELA INC   |  INTARCIA THERAPEUTICS, INC   |  EIGER BIOPHARMACEUTICALS INC   |  ALTHEOS, INC.   |  BULLET BIOTECHNOLOGY, INC.
JAY 
 
SHEPARD 
DIRECTOR
NEXTWAVE PHARMACEUTICALS INC   |  BULLET BIOTECHNOLOGY, INC.   |  VERSARTIS, INC.   |  NEURORECOVERY TECHNOLOGIES, INC.   |  INOVIO PHARMACEUTICALS, INC.   |  CESSATION THERAPEUTICS, INC.
JAMES 
 
SWARTZ 
DIRECTOR
BULLET BIOTECHNOLOGY, INC.   |  METRATECH CORP   |  GREENLIGHT BIOSCIENCES INC.
JAMES 
R. 
SWARTZ 
DIRECTOR
BULLET BIOTECHNOLOGY, INC.
THOMAS 
P. 
THERIAULT 
EXECUTIVE OFFICER
BULLET BIOTECHNOLOGY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-06-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-06-21 
2015-03-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-03-09 
2013-07-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-11 
2012-02-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#